Original Report

Mindfulness-based cancer recovery in survivors recovering from chemotherapy and radiation


 

Background Sleep impairment, fatigue, and anxiety are common conditions in cancer survivors. Small studies suggest mindfulness- based interventions may be helpful for cancer-related fatigue.

Objective To evaluate mindfulness-based cancer recovery (MBCR) for cancer survivors who are recovering from chemotherapy or radiation therapy.

Methods 42 cancer survivors who were within 6 months of completion of chemotherapy or radiation were randomized 2:1 to 8 weekly MBCR classes (n = 28) or wait-list control (n = 14). The Pittsburgh Sleep Quality Index (PSQI), Functional Assessment in Cancer Therapy – Fatigue (FACT-F), and 20-item State-Trait Anxiety Inventory (STAI) were used to assess sleep, fatigue, and anxiety at baseline (time of enrollment), at 2 months (on completion of the MBCR course), and 4 months (2 months after completion of the course). 32 of 42 participants participated in an optional blood draw to assess immune function.

Results 79% of the MBCR group attended at least 7 of the 9 MBCR sessions. At the 2-month assessment, sleep quality (PSQI, range 0-21, >5 = poorer sleep quality) in the MBCR group improved from the baseline 8.9 to 6.4, compared with the wait-list group (baseline 7.2 to 7.6); and at 4 months after course completion, it was 6.1 compared with 7.8, respectively (P = .03). There was a non-statistically significant improvement in fatigue (FACIT-F, P = .19). There was a trend toward improvement in the anxiety scores (STAI, range 20-80, higher score = greater anxiety) in the MBCR group compared with the wait-list group at 2 months (31.8 vs 39.4, respectively; P = .07) and 4 months (32.8 vs 40.7; P = .10). Immune function measures were not statistically significant.

Limitations It is possible the psychological support of being in contact with a facilitator and/or other cancer survivors had a beneficial effect in the outcomes of those in the MBCR group.

Conclusion MBCR has a high compliance rate and results in sustained improvements in sleep quality, fatigue, and anxiety. MBCR may be useful for cancer survivors struggling with sleep, fatigue, and anxiety.

Funding Hourglass Fund, Masonic Cancer Center, University of Minnesota; University of Minnesota Foundation (immune function protocol); National Institutes of Health Office of Women’s Health Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) NIH # K12-HD055887.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

ASCO: Always screen cancer survivors for chronic pain
MDedge Hematology and Oncology
Aleukemic acute lymphoblastic leukemia with unusual clinical features
MDedge Hematology and Oncology
Overweight, obesity increase risk of cardiotoxicity from anthracyclines
MDedge Hematology and Oncology
Study shows faster increase in obesity prevalence among cancer survivors
MDedge Hematology and Oncology
Triptorelin doesn’t prevent ovarian failure in young women treated for lymphoma
MDedge Hematology and Oncology
It’s health care … but not as we know it
MDedge Hematology and Oncology
Uridine triacetate provides antidote for 5-fluorouracil overdose and toxicity
MDedge Hematology and Oncology
Elotuzumab and ixazomib join the therapeutic arsenal for multiple myeloma
MDedge Hematology and Oncology
Rate of abnormal vaginal bleeding and contraception counseling in women undergoing chemotherapy
MDedge Hematology and Oncology
Effects of IV iron treatment with ferumoxytol on health-related quality of life of patients with iron deficiency anemia
MDedge Hematology and Oncology